Eng Khin Chong

Director


Eng Khin is a director of Chong Kah Capital Sdn. Bhd.


Eng Khin is an entrepreneur and full time stock investor. He holds regular seminars and talks on topics of stock investments and trading. He also runs Successive JK Ventures Sdn. Bhd., an investment research and advisory company based in Kota Kinabalu, Malaysia.


Eng Khin holds a B.A. (Geo & Philosophy/History), a Diploma in Share Trading and Investment and have completed executive education in Leadership by Cornell University. 

Investment Team

Eng Juin Chong

Managing Director

Chief Investment Officer


Eng Juin is the managing director and chief investment officer of Chong Kah Capital Sdn. Bhd. and manages the firm's investments and research activities. He has over 10 years of experience in equity and derivatives investments and holds a value approach in equity research and valuation.


Prior to establishing Chong Kah Capital he was an investment analyst at CKR Sdn. Bhd. and had a short stint at RBC Investor & Treasury Services in Sydney. Eng Juin also acted as a private investment adviser to a boutique family office.


He holds a Master of Finance from Curtin University, a Graduate Certificate in Finance from the University of Technology Sydney and a Bachelor of Biomedical Science from the University of Newcastle.

Chong Kah Capital Sdn. Bhd. - all rights reserved                                 

Email: info@chongkahcapital.com

                                                                                                                  



Lena Soo 

Director

Senior Research Analyst


Lena is a director and senior analyst heading the research on listed and private biotechnology, pharmaceutical and agricultural companies.


Lena received her Ph.D. from the University of Sydney in Molecular Biology and her B.Sc (Hons) Genetics from the National University of Malaysia. She has held several teaching positions at the University of Sydney prior to co-founding Chong Kah Capital. She brings to the investment team particular expertise in the areas of R&D and product pipeline analysis of biotechnology and pharmaceutical companies.